Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.38 USD | -0.16% | -2.60% | -.--% |
May. 14 | Metagenomi, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 07 | HC Wainwright Starts Metagenomi With Buy Rating, $10 Price Target | MT |
Business Summary
Number of employees: 237
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Ionis
49.0
%
| 0 | 0.7 % | 22 | 49.0 % | +19,466.96% |
Moderna
40.5
%
| 15 | 84.4 % | 18 | 40.5 % | +24.80% |
Affini-T
10.6
%
| 3 | 14.9 % | 5 | 10.6 % | +83.74% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 17 | 100.0 % | 45 | 100.0 % | +160.21% |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 37,464,201 | 24,916,262 ( 66.51 %) | 0 | 66.51 % |
Company contact information
Sector
Sales per Business
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-.--% | 239M | |
+43.36% | 54.63B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- MGX Stock
- Company Metagenomi, Inc.